Scripintelligence

Scrip Clinica Scrip Regulatory Affairs Scrip Clinical Research AnimalPharm

Advanced Search

Research & Development

Home - Comment

JOB OF THE WEEK Promote your vacancy here

SCRIP's ONLINE DIRECTORY
Classified ads

COMMENTARY

Dapagliflozin: 'No' from FDA advisers could spell trouble for new diabetes class
21 July 2011

ARISTOTLE: changing thinking about BMS/Pfizer's Eliquis in a...

Betanis, Tradjenta and Onbrez priced and set for launch in J...

Private investment round-up: December 2009
06 January 2010

Private investment round-up: November 2009
09 December 2009

Commentary: Japan trims the fat
18 November 2009

>> More Commentary...

EDITORIAL

Blade of truth lacerates the a web of intrigue
21 July 2011

End of an era in antibiotic blockbusters as FDA approves Lev...

South Africa mulls state-owned pharma firm...

The Great Disappearotech: shrinking before your very eyes
14 July 2011

Looking at the wider impact of the Sanofi-Genzyme deal
28 February 2011

Act global: think reputational
31 January 2011

>> More Editorial...

EXPERT VIEW

Regenerative medicine – time to cut through the hype
28 July 2011

TiGenix bulks up in merger with Cellerix...

Asia Beat: No easy answers as Philippines lays out ambitious...

J&J stent exit – another missed opportunity
21 June 2011

The EMA's financial juggling act
28 February 2011

Asia Beat: No easy answers as Philippines lays out ambitious universal care plan
23 February 2011

>> More Expert View...

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Therapy Sector

Generics

Business

Policy & Regulation

Research & Development

International

Terms & Conditions

Scrip Regulatory Affairs

Scrip Clinical Research

Animal Pharm